ADHD and growth: Anthropometric changes in medicated and non-medicated ADHD boys

Medical Science Monitor

Volumn 15, Issue 12, 2009, Pages

  Ptacek, Radek ^a   Kuzelova, Hana ^a   Paclt, Ivo ^a   Zukov, Ilja ^a   Fisher, Slavomil ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

ADHD; Anthropometry; Somatic development; Stimulant medication

Indexed keywords

METHYLPHENIDATE;

ADOLESCENT; ANTHROPOMETRY; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; BODY FAT DISTRIBUTION; BODY HEIGHT; CHILD; CHILD GROWTH; CONTROLLED STUDY; GROWTH INHIBITION; HEAD CIRCUMFERENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL ASSESSMENT; PRESCHOOL CHILD; SCHOOL CHILD;

ADOLESCENT; ANTHROPOMETRY; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BODY HEIGHT; BODY WEIGHT; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; GROWTH; HUMANS; MALE; METHYLPHENIDATE; NUTRITIONAL STATUS;

EID: 75149166233     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Culpepper L, Mattingly G: A practical guide to recognition and diagnosis of ADHD in adults in the primary care setting. Postgrad Med, 2008; 120(3): 16-26
2. Setoodeh A, Teleffson S: Attention Deficit Hyperactivity Disorder and Growth, Iran J Ped, 2007; 17(2): 183-87
3. Cormier E: Attention deficit/hyperactivity disorder: a review and update. J Pediatr Nurs Oct, 2008; 23(5): 345-57
4. Stephen VF, Kevin MA: Diagnosing and treating attention-deficit/ hyperactivity disorder in adults. World Psychiatr, 2008; 7(3): 131-36
5. Schubiner H, Katragadda S: Overview of epidemiology, clinical features, genetics, neurobiology, and prognosis of adolescent attention-deficit/ hyperactivity disorder. Adolesc Med State Art Rev, 2008; 19(2): 209-15
6. Spencer TJ: Neurobiology and genetics of ADHD in adults. CNS Spectr, 2008; 13(9): 5-7, 1
7. Lasky-Su J, Neale BM, Franke B et al: Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations. Am J Med Genet B Neuropsychiatr Genet, 2008; 26
8. Kopeckova M, Paclt I, Petrasek J et al: Some ADHD polymorphisms (in genes DAT1, DRD2, DRD3, DBH, 5-HTT) in case-control study of 100 subjects 6-10 age. Neuro Endocrinol Lett, 2008; 29(2): 246-51
9. Drtilkova I, Sery O, Theiner P et al: Clinical and molecular-genetic markers of ADHD in children. Neuro Endocrinol Lett, 2008; 29(3): 320-27
10. Kopeckova M, Paclt I, Goetz P: Polymorphisms and low plasma activity of dopamine-beta-hydroxylase in ADHD children. Neuro Endocrinol Lett, 2006; 27(6): 748-54
11. Sery O, Drtilkova I, Theiner P et al: Polymorphism of DRD2 gene and ADHD. Neuro Endocrinol Lett, 2006; 27(1-2): 236-40
12. Uhlikova P, Paclt I, Vaneckova M et al: Asymmetry of basal ganglia in children with attention deficit hyperactivity disorder. Neuro Endocrinol Lett, 2007; 28(5): 604-9
13. Bulut M, Selek S, Gergerlioglu HS et al: Malondialdehyde levels in adult attention-deficit hyperactivity disorder. J Psychiatry Neurosci, 2007; 32(6): 435-38
14. Paclt I, Koudelova J, Krepelova A et al: Biochemical markers and genetic research of ADHD. Neuro Endocrinol Lett, 2005; 26(4): 423-30
15. Kariyawasam SH, Zaw F, Handley SL: Reduced salivary cortisol in children with comorbid Attention deficit hyperactivity disorder and oppositional defiant disorder. Neuro Endocrinol Lett, 2002; 23(1): 45-48
16. Shim SH, Hwangbo Y, Kwon YJ et al: Increased levels of plasma brain-derived neurotrophic factor (BDNF) in children with attention deficit-hyperactivity disorder (ADHD). Prog Neuropsychopharmacol Biol Psychiatry, 2008; Epub ahead of print
17. Ellison-Wright I, Ellison-Wright Z, Bullmore E: Structural brain change in Attention Deficit Hyperactivity Disorder identified by meta-analysis. BMC Psychiatry, 2008; 8: 51
18. Garrett A, Penniman L, Epstein JN et al: Neuroanatomical abnormalities in adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry, 2008; 47(11): 1321-28
19. Geier DA, Mumper E, Gladfelter B et al: Neurodevelopmental disorders, maternal Rh-negativity, and Rho(D) immune globulins: a multicenter assessment. Neuro Endocrinol Lett, 2008; 29(2): 272-80
20. Crawford C, Salmon C: Psychopathology or adaptation? Genetic and evolutionary perspectives on individual differences and psychopathology. Neuro Endocrinol Lett, 2000; 23(4): 39-45
21. Matejcek Z: Is ADHD adaptive or non-adaptive behavior? Neuro Endocrinol Lett, 2003; 24(3-4): 148-50
22. Lam LT, Yang L: Overweight/obesity and attention deficit and hyperactivity disorder tendency among adolescents in China. Int J Obes (London), 2007; 31(4): 584-90
23. Zachor DA, Roberts AW, Hodgens JB et al: Effect of long-term psychostimulant medication on growth of children with AD(H)D. Res Dev Disabil, 2006; 27(2): 162-74
24. Hrdlicka M, Zedkova I, Blatny M, Urbanek T: Weight gain associated with atypical and typical antipsychotics during treatment of adolescent schizophrenic psychoses: A retrospective study. Neuro Endocrinol Lett, 2009; 30(2): 256-61
25. Hubel R, Jass J, Marcus A, Leassle RG: Overweight and basal metabolic rate in boys with attention-deficit/hyperactivity disorder. Eat Weight Disord, 2006; 11(3): 139-46
26. Holtkamp K, Konrad K, Miller B et al: Overweight and obesity in children with Attention-Deficit/Hyperactivity Disorder. Int J Obes, 2004; 28(5): 685-89
27. Altafas JR: Prevalence of attention deficit/hyperactivity disorder among adults in obesity treatment. BMC Psychiatry, 2002; 2: 9
28. Waring ME, Lapane KL: Overweight in Children and Adolescents in Relation to Attention-Deficit/Hyperactivity Disorder: Results From a National Sample. Pediatrics, 2008; 122(1): 1-6
29. Mustillo S, Worthman C, Erkanli A et al: Obesity and Psychiatric disorder: Developmental Trajectories. Pediatrics, 2003; 111: 851-59
30. Trtilkova I: The effectiveness of non-standard treatment process in children with ADHD [Ucinnost nestandardni lecbz u deti s ADHD]. Ces a Slov Psych, 2003; 99(6): 317-23
31. LinksSo CY, Leung PW, Hung SF: Treatment effectiveness of combined medication/behavioural treatment with Chinese ADHD children in routine practice. Behav Res Ther, 2008
32. nd ed.). New York, Plenum, 1999
33. rd ed.). New York, Blackwell, 2005
34. Paclt I: The hyperkinetic disorder [Hyperkynetická porucha chování]. Praha: Grada, 2008
35. Spencer T, Biederman J, Wilens T: Growth deficits in children with attention deficit hyperactivity disorder. Pediatrics, 1998; 102: 501-6
36. Rao JK, Julius JR, Breen TJ, Blethen SL: Response to Growth Hormone in Attention Deficit Hyperactivity Disorder: Effects of Methylphenidate and Pemoline Therapy. Pediatrics, 1998; 102(2): 497-500
37. Safer DJ, Allen RP, Barr E: Depression of growth in hyperactive children on stimulant drugs. N Engl J Med, 1972; 287: 217-20
38. Spencer T, Biederman J, Wilens T: Growth deficits in children with attention deficit hyperactivity disorder. Pediatrics, 1998; 102: 501-6
39. Paclt I, Ptacek R, Florian J: Hyperactivity [Hyperaktivita]. Praha: Vzdelavaci institute ochrany deti. 2006
40. Paclt I, Florian J: Attention deficit in hyperactive children [Deficit pozornosti u hyperaktivních dětí]. Ces a Slov Psych, 1996; 1: 23
41. Poulton A: Growth on stimulant medication; clarifying the confusion: a review. Arch Dis Child, 2005; 90: 801-6
42. Friedmann N, Thomas J, Carr R et al: Effect on growth in pemoline-treated children with attention deficit disorder. Am J Dis Child, 1981; 135: 329-32
43. Prihodova I, Nevsimalova S: Sleep and attention deficit hyperactivity disorder - a summary of current findings. [Spanek a porucha pozornosti s hyperaktivitou - souhrn současných poznatků]. Ces a Slov Psych, 2006; 102(2): 80-84
44. McAfee AT, Holdridge KC, Johannes CB et al: The effect of pharmacotherapy for attention deficit hyperactivity disorder on risk of seizures in pediatric patients as assessed in an insurance claims database. Curr Drug Saf, 2008; 3(2): 123-31
45. Paclt I, Uhlikova P, Koudelova J et al: Biological markers of the hyperkinetic syndrome in children of age 6 to 10 years. Eur Psychiatr, 2000; 10(2): 385
46. Satterfield JH, Cantwell DP, Schell A, Blaschke T: Growth of hyperactive children treated with methylphenidate. Arch Gen Psychiatry, 1979; 36: 212-17
47. Mattes JA, Gittelman R: Growth of hyperactive children on maintenance regimen of methylphenidate. Arch Gen Psychiatry, 1983; 40: 317-21
48. Faraone SV, Giefer EE: Long-term effects of methylphenidate transdermal delivery system treatment of ADHD on growth. J Am Acad Child Adolesc Psychiatry, 2007; 46(9): 1138-47
49. Poulton AS, Nanan R: Prior treatment with stimulant medication: a much neglected confounder of studies of growth in children with attention-deficit/ hyperactivity disorder. J Child Adolesc Psychopharmacol, 2008; 18(4): 385-87
50. McGee R, Birkbeck J, Silva PA: Physical development of hyperactive boys. Dev Med Child Neurol, 1985; 27(3): 364-68
51. Lipowski M, Buliński L, Krawczyński M: Physical activities among other types of health-related behaviour in people losing weight. Med Sci Monit, 2009; 15(8): CR423-28
52. Kosti RI, Panagiotakos DB, Mihas CC et al: Dietary habits, physical activity and prevalence of overweight/obesity among adolescents in Greece: the Vyronas study. Med Sci Monit, 2007; 13(10): CR437-44
53. Guerrieri R, Nederkoorn C, Jansen A: The interaction between impulsivity and a varied food environment: its influence on food intake and overweight. Int J Obes, 2008; 32(4): 708-14
54. th Edition, American Psychiatric Association, 1994
55. Conners CK: Trachet Questionnaire. Psychopharm Bull, 1985; 21(4): 823-31
56. Blaha P, Vignerova J, Paulova M et al: The development of body parameters of Czech children and adolescents focusing on head parameters. 0-16 years [Vývoj tělesných parametrů českých dětí a mládeže se zaměřením na rozměry hlavy (0-16 let)]. Praha: SZÚ
57. Blaha P, Vignerova J, Riedlova J et al: The sixth national antropological research of children and adolescents 2001 [VI. celostátní antropologický výzkum dětí a mládeže 2001]. Česko-slovenská Pediatrie, 2003; 58(12): 766-70
58. Viegnerova J, Riedlova J, Blaha P: Program Rust CZ, Manual (Program Růst CZ, Manuál]. Praha: SZÚ, 2005
59. Ptacek R, Kuzelova H, Paclt I, Zukov I: Effect of Medication on anthropometric characteristics of ADHD children. Ces a slov Psychiat, 2008; 104(8): 415-19
60. Ptacek R, Kuzelova H, Paclt I et al: Somatic and endocrinological changes in non medicated ADHD children. Prague Med Rep, 2009; 110(1): 25-34
61. Ptacek R, Kuzelova H, Zukov I et al: Height and weight in medicated children with ADHD. Activitas Superior, 2009; 51(4), in press.
62. Torrey EF, Dhavale D, Lawlor JP, Yolken RH: Autism and head circumference in the first year of life. Biol Psych, 2004; 11(1): 892-94
63. Takagai S, Kawai M, Toulopoulou T et al: Increased rate of birth complications and small head size at birth in winter-born male patients with schizophrenia. Schizophrenia Res, 2006; 83(2-3): 303-5
64. Ptacek R, Kuzelova H, Paclt I et al: Anthropometric changes in nonmedicated ADHD boys. Neuro Endocrinol Lett, 2009; 30(3): In press